日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Optimisation of a primary human CAR-NK cell manufacturing pipeline

优化人类 CAR-NK 细胞原代生产流程

Aline Pfefferle, Julian Contet, Kahlia Wong, Charlotte Chen, Els Verhoeyen, Chloe K Slichter, Kimberly S Schluns, Joseph Cursons, Richard Berry, Iva Nikolic, Jai Rautela, Nicholas D Huntington

In vivo measurement of NADH fluorescence lifetime in skeletal muscle via fiber-coupled time-correlated single photon counting

利用纤维耦合时间相关单光子计数法对骨骼肌中NADH荧光寿命进行体内测量

Priest, Kathryn M; Schluns, Jacob V; Nischal, Nathania; Gattis, Colton L; Wolchok, Jeffrey C; Muldoon, Timothy J

Transcriptome profiling of a synergistic volumetric muscle loss repair strategy

协同性肌肉体积损失修复策略的转录组分析

Roberts, Kevin; Kim, John Taehwan; Huynh, Tai; Schluns, Jacob; Dunlap, Grady; Hestekin, Jamie; Wolchok, Jeffrey C

NKTR-255 is a polymer-conjugated IL-15 with unique mechanisms of action on T and natural killer cells

NKTR-255 是一种聚合物结合的 IL-15,对 T 细胞和自然杀伤细胞具有独特的作用机制

Tanya O Robinson, Shweta M Hegde, Allison Chang, Achintyan Gangadharan, Sarai Rivas, Loui Madakamutil, Jonathan Zalevsky, Takahiro Miyazaki, Kimberly S Schluns

Thymic Epithelial Cell-Derived IL-15 and IL-15 Receptor α Chain Foster Local Environment for Type 1 Innate Like T Cell Development

胸腺上皮细胞衍生的 IL-15 和 IL-15 受体 α 链促进 1 型先天性 T 细胞发育的局部环境

Huishan Tao, Lei Li, Nan-Shih Liao, Kimberly S Schluns, Shirley Luckhart, John W Sleasman, Xiao-Ping Zhong

The deubiquitinase Otub1 controls the activation of CD8(+) T cells and NK cells by regulating IL-15-mediated priming

去泛素化酶Otub1通过调节IL-15介导的启动作用来控制CD8(+) T细胞和NK细胞的活化。

Zhou, Xiaofei; Yu, Jiayi; Cheng, Xuhong; Zhao, Baoyu; Manyam, Ganiraju C; Zhang, Li; Schluns, Kimberly; Li, Pingwei; Wang, Jing; Sun, Shao-Cong

IL-15 is a component of the inflammatory milieu in the tumor microenvironment promoting antitumor responses

IL-15是肿瘤微环境中炎症反应的组成部分,可促进抗肿瘤反应。

Santana Carrero, Rosa M; Beceren-Braun, Figen; Rivas, Sarai C; Hegde, Shweta M; Gangadharan, Achintyan; Plote, Devin; Pham, Gabriel; Anthony, Scott M; Schluns, Kimberly S

The development of interferon-based gene therapy for BCG unresponsive bladder cancer: from bench to bedside

干扰素基因疗法治疗卡介苗无反应性膀胱癌的研发:从实验室到临床

Duplisea, Jonathan J; Mokkapati, Sharada; Plote, Devin; Schluns, Kimberly S; McConkey, David J; Yla-Herttuala, Seppo; Parker, Nigel R; Dinney, Colin P

Inhibition of urothelial carcinoma through targeted type I interferon-mediated immune activation

通过靶向 I 型干扰素介导的免疫激活抑制尿路上皮癌

Devin Plote, Woonyoung Choi, Sharada Mokkapati, Debasish Sundi, James E Ferguson 3rd, Jon Duplisea, Nigel R Parker, Seppo Yla-Herttuala, Suo Ctc Bladder Committee, David McConkey, Kimberly S Schluns, Colin P Dinney

Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy

癌症疫苗配方决定与 CTLA-4 和 PD-L1 检查点阻断疗法的协同作用

Yared Hailemichael, Amber Woods, Tihui Fu, Qiuming He, Michael C Nielsen, Farah Hasan, Jason Roszik, Zhilan Xiao, Christina Vianden, Hiep Khong, Manisha Singh, Meenu Sharma, Faisal Faak, Derek Moore, Zhimin Dai, Scott M Anthony, Kimberly S Schluns, Padmanee Sharma, Victor H Engelhard, Willem W Overw